Stout is pleased to announce that John Calcagnini has joined as Managing Director in the Investment Banking group’s healthcare industry practice.
Mr. Calcagnini brings extensive experience with mergers, acquisitions, divestitures, joint ventures, restructurings, and equity and debt financings, and he has successfully executed more than 40 transactions in the healthcare industry. Prior to joining Stout, Mr. Calcagnini was Head of Healthcare at CRT Capital Group and Head of Medical Device Investment Banking in the healthcare practice at CIBC World Markets/Oppenheimer.
“Stout is known for deep industry expertise, and I’m thrilled to add even greater depth to our team,” said Nick Jachim, Managing Director and Head of Investment Banking at Stout. “John has worked with some of the most dynamic companies across a variety of sectors including biotech, specialty pharmaceuticals, and medical devices. We can’t wait to leverage his insights to create value for new clients in the healthcare arena.”
“It couldn’t be a more exciting time to apply my healthcare background across Stout’s investment banking platform,” said Mr. Calcagnini, “It’s fantastic to join a team of highly respected industry experts and help continue the tremendous growth at this firm.”
Mr. Calcagnini holds a B.S. in Economics from State University of New York and has been recognized three times by The Wall Street Journal as an All Star Equity Research Analyst. He will reside in Stout’s Los Angeles office.
Stout is a premier global advisory firm specializing in Investment Banking, Valuation Advisory, Dispute Consulting, and Management Consulting. We serve a range of clients from Fortune 500 corporations to privately held companies in numerous industries around the world. Our clients and their advisors rely on our premier expertise, deep industry knowledge, and unparalleled responsiveness on complex financial matters.
Stout is a trade name for Stout Risius Ross, LLC and Stout Risius Ross Advisors, LLC, a FINRA registered broker-dealer and SIPC member firm.